Page last updated: 2024-08-24

trovafloxacin and Chromosomal Translocation

trovafloxacin has been researched along with Chromosomal Translocation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barra, M; Bol-Schoenmakers, M; Giustarini, G; Huppelschoten, S; Klingmüller, U; Oppelt, A; Pieters, RHH; Smit, JJ; van de Water, B; Wagenaar, L; Weaver, RJ	1

Other Studies

1 other study(ies) available for trovafloxacin and Chromosomal Translocation

Article	Year
The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro. Toxicology and applied pharmacology, 2020, 03-15, Volume: 391 Topics: Animals; Anti-Bacterial Agents; Apoptosis; Chemical and Drug Induced Liver Injury; Cytokines; Fluoroquinolones; Humans; I-kappa B Proteins; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinases; Naphthyridines; RAW 264.7 Cells; Transcription Factor RelA; Translocation, Genetic; Tumor Necrosis Factor-alpha	2020

Article

Year

The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro.

Toxicology and applied pharmacology, 2020, 03-15, Volume: 391

Topics: Animals; Anti-Bacterial Agents; Apoptosis; Chemical and Drug Induced Liver Injury; Cytokines; Fluoroquinolones; Humans; I-kappa B Proteins; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinases; Naphthyridines; RAW 264.7 Cells; Transcription Factor RelA; Translocation, Genetic; Tumor Necrosis Factor-alpha

2020